One BioMed launches the cartridge-based Xceler8™ Nucleic Acid Extraction Platform, the next generation in workflow simplification -- MEDICA - World Forum for Medicine

10/11/2021

BK Electronics Co., Ltd.

One BioMed launches the cartridge-based Xceler8™ Nucleic Acid Extraction Platform, the next generation in workflow simplification


One BioMed, a company focused on advancing human health through innovation, announced today the launch of their Xceler8TM Platform for high- yield extraction and purification of nucleic acids from biological samples. Pre-filled with all the necessary reagents, X8TM Cartridge Kits, powered by the OneTouch Instrument and its touchscreen tablet, automate all nucleic acid extraction steps, including cell lysis, capture, washing and elution in as little as 30 minutes. With the flexibility of random access, the Xceler8 Solution, the first of its kind, has the ability to run different protocols simultaneously, with less than one minute of hands-on time per sample.

One BioMed’s patented chemistry-based technology simplifies the product architecture, eliminating the need for expensive robotics and complex setup. The load-and-go approach unlike conventional spin-column or magnetic beads methods, makes it ideal for labs looking for high flexibility at an affordable price. The Xceler8 Platform ensures consistent and reproducible extraction of nucleic acids from a myriad of sample types across different users. The extracted DNA or RNA can be used for a variety of downstream applications such as sequencing, PCR and gel electrophoresis. With the ability to run up to 8 samples per run, users can process up to 500 samples per week. The fully integrated system eliminates the need for ancillary equipment and user-supplied reagents, thus providing a seamless and truly walk-away experience.

BK Electronics is the ODM partner of One BioMed for the development of Xceler8™.

Exhibitor Data Sheet